Emerging Biosensing Technologies for the Diagnostics of Viral Infectious Diseases (Adv. Mater. 30/2022)

Emerging Biosensing Technologies for the Diagnostics of Viral Infectious Diseases (Adv. Mater. 30/2022)

Biosensors The speed of innovation in the development, commercialization, and implementation of new technologies for infectious disease diagnostics has enabled humans to better combat the COVID‐19 pandemic. In article number 2201085, Kiana Aran, Can Dincer, and co‐workers highlight the development o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Weinheim) 2022-07, Vol.34 (30), p.n/a
Hauptverfasser: Kabay, Gözde, DeCastro, Jonalyn, Altay, Alara, Smith, Kasey, Lu, Hsiang‐Wei, Capossela, Antonia McDonnell, Moarefian, Maryam, Aran, Kiana, Dincer, Can
Format: Artikel
Sprache:eng
Schlagworte:
biosensors
CRISPR/Cas technology
host immune response
point‐of‐care testing
viruses
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Biosensors The speed of innovation in the development, commercialization, and implementation of new technologies for infectious disease diagnostics has enabled humans to better combat the COVID‐19 pandemic. In article number 2201085, Kiana Aran, Can Dincer, and co‐workers highlight the development of various novel and reimagined multiomic sensing technologies to address the gaps in testing and surveillance for future outbreaks of coronaviruses and other infectious diseases.
ISSN:0935-9648
1521-4095
DOI:10.1002/adma.202270224